Jeffry Pilney
New Martinsville, WVNPI 1487601647
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,904 of the $3,999 with a category attached, or 72.6%. AstraZeneca accounts for 65.8% of it on its own, with 1 other manufacturer making up the rest.
Across 29 payments — averaging $137.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Modernatx, Inc.$1K
Across 561 payments — averaging $3841.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$610K
- Ipsen Innovation$359K
- AbbVie$347K
- Genentech, Inc.$272K
- Modernatx, Inc.$229K
- Orasure Technologies Inc.$110K
- plus $228K from 5 others
What the payments were for
- Travel & lodging$2,90473%
- Food & beverage$1,09627%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 19 | $2,633 |
| Modernatx, Inc. | 10 | $1,366 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.